Full year results and update on growth strategy
28/04/2022
RNS
DHSC dispute update
26/04/2022
Notice of Results and Investor Presentation
20/04/2022
Approval of COVID-19 test under CTDA legislation
12/04/2022
Liquidity Agreement Update and Total Voting Rights
01/04/2022
Director/PDMR Shareholding
25/03/2022
Director/PCA Dealing
18/03/2022
15/03/2022
Holdings in Company
11/03/2022
01/03/2022
18/02/2022
17/02/2022
15/02/2022
Long Term Incentive Plan
04/02/2022
Liquidity Agreement and Total Voting Rights
01/02/2022
Strategy and Full Year 2021 Trading Update
25/01/2022
04/01/2022
Total Voting Rights
01/12/2021
26/11/2021
Validation of COVID-19 tests in the UK under CTDA
02/11/2021
For Investor Relations Support for the Novacyt Group, please click the button below to contact our team.
